Delivery Order SPE2DB22D2206-SPE2DB24FFY76
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,313.66 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563588342 - VRAYLAR 6 MG CAPSULE 30S. This delivery order contract has a completion date of February 8, 2024 and was awarded on February 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,259,825 units of the pharmaceutical product VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $5,226.62 and a completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The $4,426.60 contract has a performance period through March 5, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,962.56 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the provision of VRAYLAR 3 MG Capsules and has a period of performance through January 29, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,636.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S. This contract, with a completion date of March 6, 2024, is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $10,793.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VRAYLAR 1.5 MG CAPSULE 30S. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a potential value of $3,526.51 and a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $10,529.83 firm fixed price delivery order contract to provide VRAYLAR 3 MG CAPSULE 30S, a specialty pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of VRAYLAR 1.5 MG CAPSULE 30S. The contract, valued at $3,791.54, has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563743133 - VRAYLAR 1.5 MG CAPSULE 30S. The contract has a potential value of $10,584.13 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFY76Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 6 MG CAPSULE 30S. The delivery order has a potential value of $5,313.66 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 3/6/24 |